Bayer AG
XETRA:BAYN
Bayer AG
XETRA:BAYN
Price:
28.13 EUR
2.85%
Market Closed
Updated:
May 3, 2024
Bayer AG
Other Current Liabilities
|
Bayer AG
Other Current Liabilities Peer Comparison
Comparables:
ATAI
MRK
93M1
DMP
PSG
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bayer AG
XETRA:BAYN
|
Other Current Liabilities
€15.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
3%
|
CAGR 10-Years
10%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Other Current Liabilities
$715k
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
Other Current Liabilities
€5.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
10%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Other Current Liabilities
€4m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
101%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Other Current Liabilities
€191.4m
|
CAGR 3-Years
50%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Other Current Liabilities
€5.9m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Other Current Liabilities?
Other Current Liabilities
15.2B
EUR
15.2B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Other Current Liabilities amounts to 15.2B EUR.
What is Bayer AG's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
10%
10%
Over the last year, the Other Current Liabilities growth was -23%. The average annual Other Current Liabilities growth rates for Bayer AG have been -12% over the past three years , 3% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
